# Gilead Sciences timeline entity: /record/gilead-sciences.md id: ent_gilead-sciences Gilead Sciences' timeline holds 533 claims from 1994 to 2026: 524 money & deals, 9 other. 8 are undated. The latest took effect on October 23, 2026. Kinds: People 0 (/timelines/gilead-sciences.md?kind=people) · Money & deals 524 (/timelines/gilead-sciences.md?kind=money) · Products 0 (/timelines/gilead-sciences.md?kind=products) · Models 0 (/timelines/gilead-sciences.md?kind=models) · Other 9 (/timelines/gilead-sciences.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 1994 - 1994-02-14 | other | registrant_name | GILEAD SCIENCES, INC. | valid | [clm_B758636654A0](/claim/clm_B758636654A0.md) ## 2006 - 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 816,007,000 United States dollar | superseded | [clm_7743456F80CE](/claim/clm_7743456F80CE.md) - 2006-12-31 to 2007-12-31 | money | total_equity | 2,051,546,000 United States dollar | superseded | [clm_616F12FEE3F3](/claim/clm_616F12FEE3F3.md) ## 2007 - 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 968,086,000 United States dollar | superseded | [clm_9D59E814F648](/claim/clm_9D59E814F648.md) - 2007-12-31 to 2008-12-31 | money | net_income | 1,584,902,000 United States dollar | superseded | [clm_9F8A791EDBD9](/claim/clm_9F8A791EDBD9.md) - 2007-12-31 to 2008-12-31 | money | operating_income | 2,164,507,000 United States dollar | superseded | [clm_C1A5FF719A45](/claim/clm_C1A5FF719A45.md) - 2007-12-31 to 2008-12-31 | money | revenue | 4,230,045,000 United States dollar | superseded | [clm_2896D3FD1A51](/claim/clm_2896D3FD1A51.md) - 2007-12-31 to 2008-12-31 | money | total_equity | 3,752,630,000 United States dollar | superseded | [clm_BF1309BFEE2D](/claim/clm_BF1309BFEE2D.md) ## 2008 - 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 1,119,599,000 United States dollar | superseded | [clm_FCE3CE1DC9A4](/claim/clm_FCE3CE1DC9A4.md) - 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 434,783,000 United States dollar | superseded | [clm_F1BABC75C9BC](/claim/clm_F1BABC75C9BC.md) - 2008-06-30 to 2008-09-30 | money | quarterly_operating_income | 605,515,000 United States dollar | superseded | [clm_AF94D3CB0BC1](/claim/clm_AF94D3CB0BC1.md) - 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 1,278,125,000 United States dollar | superseded | [clm_226CF11D49AD](/claim/clm_226CF11D49AD.md) - 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 1,209,424,000 United States dollar | superseded | [clm_71CF9DEE2C5F](/claim/clm_71CF9DEE2C5F.md) - 2008-09-30 to 2009-03-31 | money | quarterly_net_income | 495,853,000 United States dollar | superseded | [clm_558B16EA5C7C](/claim/clm_558B16EA5C7C.md) - 2008-09-30 to 2009-03-31 | money | quarterly_operating_income | 693,834,000 United States dollar | superseded | [clm_7989DECF12D6](/claim/clm_7989DECF12D6.md) - 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 1,371,268,000 United States dollar | superseded | [clm_B6FDE1DA7495](/claim/clm_B6FDE1DA7495.md) - 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 1,459,302,000 United States dollar | superseded | [clm_A15E9B5FEB96](/claim/clm_A15E9B5FEB96.md) - 2008-12-31 to 2009-12-31 | money | net_income | 1,978,899,000 United States dollar | superseded | [clm_35D02F2808B3](/claim/clm_35D02F2808B3.md) - 2008-12-31 to 2009-12-31 | money | operating_income | 2,678,541,000 United States dollar | superseded | [clm_090DE766E964](/claim/clm_090DE766E964.md) - 2008-12-31 to 2009-12-31 | money | revenue | 5,335,750,000 United States dollar | superseded | [clm_78AFDF7AC308](/claim/clm_78AFDF7AC308.md) - 2008-12-31 to 2009-06-30 | money | total_assets | 6,936,831,000 United States dollar | superseded | [clm_E3E637C171EE](/claim/clm_E3E637C171EE.md) - 2008-12-31 to 2009-06-30 | money | total_equity | 4,272,573,000 United States dollar | superseded | [clm_02B160679CDF](/claim/clm_02B160679CDF.md) ## 2009 - 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 1,663,646,000 United States dollar | superseded | [clm_56A15A606CEF](/claim/clm_56A15A606CEF.md) - 2009-03-31 to 2009-06-30 | money | quarterly_net_income | 589,112,000 United States dollar | superseded | [clm_6B051E490584](/claim/clm_6B051E490584.md) - 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | 808,316,000 United States dollar | superseded | [clm_D580476ACDEA](/claim/clm_D580476ACDEA.md) - 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 1,530,460,000 United States dollar | superseded | [clm_6C439F1205CB](/claim/clm_6C439F1205CB.md) - 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 1,040,874,000 United States dollar | superseded | [clm_BBB5026F2E31](/claim/clm_BBB5026F2E31.md) - 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 571,398,000 United States dollar | superseded | [clm_695C397CCD54](/claim/clm_695C397CCD54.md) - 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | 761,061,000 United States dollar | superseded | [clm_1F54E418D5B7](/claim/clm_1F54E418D5B7.md) - 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 1,647,155,000 United States dollar | superseded | [clm_409B6A3263EA](/claim/clm_409B6A3263EA.md) - 2009-06-30 to 2009-09-30 | money | total_assets | 8,387,092,000 United States dollar | superseded | [clm_9B0E04E191E1](/claim/clm_9B0E04E191E1.md) - 2009-06-30 to 2009-09-30 | money | total_equity | 5,189,851,000 United States dollar | superseded | [clm_912C3B816D46](/claim/clm_912C3B816D46.md) - 2009-07-31 to 2009-10-30 | money | shares_outstanding | 904,261,310 shares | superseded | [clm_F2F37AF506D8](/claim/clm_F2F37AF506D8.md) - 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 1,024,599,000 United States dollar | superseded | [clm_1DD26E92789F](/claim/clm_1DD26E92789F.md) - 2009-09-30 to 2010-03-31 | money | quarterly_net_income | 673,033,000 United States dollar | superseded | [clm_E5F680B5FF62](/claim/clm_E5F680B5FF62.md) - 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | 894,406,000 United States dollar | superseded | [clm_FC1BDAE84C91](/claim/clm_FC1BDAE84C91.md) - 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 1,801,389,000 United States dollar | superseded | [clm_6A5B983F30CE](/claim/clm_6A5B983F30CE.md) - 2009-09-30 to 2009-12-31 | money | total_assets | 8,936,980,000 United States dollar | superseded | [clm_E64B83E77382](/claim/clm_E64B83E77382.md) - 2009-09-30 to 2009-12-31 | money | total_equity | 5,646,538,000 United States dollar | superseded | [clm_814FA38F27EA](/claim/clm_814FA38F27EA.md) - 2009-10-30 to 2010-02-19 | money | shares_outstanding | 899,925,051 shares | superseded | [clm_E6FBDCCF9039](/claim/clm_E6FBDCCF9039.md) - 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 1,272,958,000 United States dollar | superseded | [clm_17191420B94F](/claim/clm_17191420B94F.md) - 2009-12-31 to 2010-12-31 | money | net_income | 2,635,755,000 United States dollar | superseded | [clm_C3B225B42864](/claim/clm_C3B225B42864.md) - 2009-12-31 to 2010-12-31 | money | operating_income | 3,529,221,000 United States dollar | superseded | [clm_C64800E0E7CB](/claim/clm_C64800E0E7CB.md) - 2009-12-31 to 2010-12-31 | money | revenue | 7,011,383,000 United States dollar | superseded | [clm_23ACEDC261B0](/claim/clm_23ACEDC261B0.md) - 2009-12-31 to 2010-03-31 | money | total_assets | 9,698,559,000 United States dollar | superseded | [clm_78A0730C637B](/claim/clm_78A0730C637B.md) - 2009-12-31 to 2010-03-31 | money | total_equity | 6,367,065,000 United States dollar | superseded | [clm_3163182F8E92](/claim/clm_3163182F8E92.md) ## 2010 - 2010-02-19 to 2010-04-30 | money | shares_outstanding | 903,378,986 shares | superseded | [clm_8CAAAB1E52C8](/claim/clm_8CAAAB1E52C8.md) - 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 936,880,000 United States dollar | superseded | [clm_1164210268A4](/claim/clm_1164210268A4.md) - 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 854,901,000 United States dollar | superseded | [clm_179B9A3F4355](/claim/clm_179B9A3F4355.md) - 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | 1,161,141,000 United States dollar | superseded | [clm_FF1303054202](/claim/clm_FF1303054202.md) - 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 2,085,853,000 United States dollar | superseded | [clm_94692F85C62C](/claim/clm_94692F85C62C.md) - 2010-03-31 to 2010-06-30 | money | total_assets | 10,695,998,000 United States dollar | superseded | [clm_25260B33C1B4](/claim/clm_25260B33C1B4.md) - 2010-03-31 to 2010-06-30 | money | total_equity | 7,341,996,000 United States dollar | superseded | [clm_B1C0CFC36770](/claim/clm_B1C0CFC36770.md) - 2010-04-30 to 2010-07-31 | money | shares_outstanding | 889,915,070 shares | superseded | [clm_0EFC19D5D09D](/claim/clm_0EFC19D5D09D.md) - 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 1,482,639,000 United States dollar | superseded | [clm_1C850A47D02B](/claim/clm_1C850A47D02B.md) - 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 712,061,000 United States dollar | superseded | [clm_60B45A77886C](/claim/clm_60B45A77886C.md) - 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | 992,627,000 United States dollar | superseded | [clm_DB4269EFC676](/claim/clm_DB4269EFC676.md) - 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 1,927,224,000 United States dollar | superseded | [clm_5442C3CA182A](/claim/clm_5442C3CA182A.md) - 2010-06-30 to 2010-09-30 | money | total_assets | 10,496,708,000 United States dollar | superseded | [clm_48FDDE6A06BE](/claim/clm_48FDDE6A06BE.md) - 2010-06-30 to 2010-09-30 | money | total_equity | 6,562,495,000 United States dollar | superseded | [clm_7D72B6AC9B7E](/claim/clm_7D72B6AC9B7E.md) - 2010-07-31 to 2010-10-29 | money | shares_outstanding | 838,632,586 shares | superseded | [clm_A22E6E059246](/claim/clm_A22E6E059246.md) - 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 1,022,993,000 United States dollar | superseded | [clm_EC9A7EDCAE43](/claim/clm_EC9A7EDCAE43.md) - 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 704,876,000 United States dollar | superseded | [clm_EDF797644901](/claim/clm_EDF797644901.md) - 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | 979,073,000 United States dollar | superseded | [clm_D24119C16413](/claim/clm_D24119C16413.md) - 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 1,937,656,000 United States dollar | superseded | [clm_E81E791E414C](/claim/clm_E81E791E414C.md) - 2010-09-30 to 2010-12-31 | money | total_assets | 11,455,591,000 United States dollar | superseded | [clm_35B4BBB949FD](/claim/clm_35B4BBB949FD.md) - 2010-09-30 to 2010-12-31 | money | total_equity | 5,706,314,000 United States dollar | superseded | [clm_BA2733FE8D7B](/claim/clm_BA2733FE8D7B.md) - 2010-10-29 to 2011-02-18 | money | shares_outstanding | 811,867,667 shares | superseded | [clm_21239540FB7C](/claim/clm_21239540FB7C.md) - 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 907,879,000 United States dollar | superseded | [clm_428390C0A446](/claim/clm_428390C0A446.md) - 2010-12-31 to 2011-12-31 | money | net_income | 2,901,257,000 United States dollar | superseded | [clm_F033D3C42EC9](/claim/clm_F033D3C42EC9.md) - 2010-12-31 to 2011-12-31 | money | operating_income | 3,962,222,000 United States dollar | superseded | [clm_2C4E606A042E](/claim/clm_2C4E606A042E.md) - 2010-12-31 to 2011-12-31 | money | revenue | 7,949,420,000 United States dollar | superseded | [clm_819CF52FBEB1](/claim/clm_819CF52FBEB1.md) - 2010-12-31 to 2011-03-31 | money | total_assets | 11,592,630,000 United States dollar | superseded | [clm_FF9FE6679302](/claim/clm_FF9FE6679302.md) - 2010-12-31 to 2011-03-31 | money | total_equity | 5,863,729,000 United States dollar | superseded | [clm_B3A3FCFB5B2E](/claim/clm_B3A3FCFB5B2E.md) ## 2011 - 2011-02-18 to 2011-04-29 | money | shares_outstanding | 795,264,644 shares | superseded | [clm_38CA76B552E6](/claim/clm_38CA76B552E6.md) - 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 1,835,978,000 United States dollar | superseded | [clm_DA423A0F862C](/claim/clm_DA423A0F862C.md) - 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 651,141,000 United States dollar | superseded | [clm_92A5B85265B5](/claim/clm_92A5B85265B5.md) - 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | 901,969,000 United States dollar | superseded | [clm_62BE5B94324C](/claim/clm_62BE5B94324C.md) - 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 1,926,094,000 United States dollar | superseded | [clm_1391B52ED0E7](/claim/clm_1391B52ED0E7.md) - 2011-03-31 to 2011-06-30 | money | total_assets | 12,987,354,000 United States dollar | superseded | [clm_83C8E8B7607D](/claim/clm_83C8E8B7607D.md) - 2011-03-31 to 2011-06-30 | money | total_equity | 5,946,253,000 United States dollar | superseded | [clm_37E625A398A2](/claim/clm_37E625A398A2.md) - 2011-04-29 to 2011-07-29 | money | shares_outstanding | 787,054,365 shares | superseded | [clm_945AE266BF3E](/claim/clm_945AE266BF3E.md) - 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 905,779,000 United States dollar | superseded | [clm_0A415A5A9101](/claim/clm_0A415A5A9101.md) - 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 746,227,000 United States dollar | superseded | [clm_701712B0358C](/claim/clm_701712B0358C.md) - 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 1,016,718,000 United States dollar | superseded | [clm_0ECE630659F3](/claim/clm_0ECE630659F3.md) - 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 2,137,253,000 United States dollar | superseded | [clm_25328C0EEB54](/claim/clm_25328C0EEB54.md) - 2011-06-30 to 2011-09-30 | money | total_assets | 12,694,140,000 United States dollar | superseded | [clm_13EE23B014A4](/claim/clm_13EE23B014A4.md) - 2011-06-30 to 2011-09-30 | money | total_equity | 6,046,845,000 United States dollar | superseded | [clm_3834A1B5CB30](/claim/clm_3834A1B5CB30.md) - 2011-07-29 to 2011-10-28 | money | shares_outstanding | 771,455,146 shares | superseded | [clm_16C8F46A3318](/claim/clm_16C8F46A3318.md) - 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 909,359,000 United States dollar | superseded | [clm_A15E593F7D06](/claim/clm_A15E593F7D06.md) - 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 741,124,000 United States dollar | superseded | [clm_E36AEE86C835](/claim/clm_E36AEE86C835.md) - 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 1,003,678,000 United States dollar | superseded | [clm_3A732D3657F3](/claim/clm_3A732D3657F3.md) - 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 2,121,660,000 United States dollar | superseded | [clm_014BF0FFC36B](/claim/clm_014BF0FFC36B.md) - 2011-09-30 to 2011-12-31 | money | total_assets | 12,639,898,000 United States dollar | superseded | [clm_F5164DFA9D86](/claim/clm_F5164DFA9D86.md) - 2011-09-30 to 2011-12-31 | money | total_equity | 6,116,764,000 United States dollar | superseded | [clm_E02857054536](/claim/clm_E02857054536.md) - 2011-10-28 to 2012-02-10 | money | shares_outstanding | 751,139,232 shares | superseded | [clm_6CB5D3B4BCE5](/claim/clm_6CB5D3B4BCE5.md) - 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 9,883,777,000 United States dollar | superseded | [clm_1CA54A90EE0E](/claim/clm_1CA54A90EE0E.md) - 2011-12-31 to 2012-12-31 | money | net_income | 2,803,637,000 United States dollar | superseded | [clm_696C99F8BC73](/claim/clm_696C99F8BC73.md) - 2011-12-31 to 2012-12-31 | money | operating_income | 3,789,841,000 United States dollar | superseded | [clm_BB578960787F](/claim/clm_BB578960787F.md) - 2011-12-31 to 2012-12-31 | money | research_and_development | 1,229,151,000 United States dollar | superseded | [clm_CB687DD570D4](/claim/clm_CB687DD570D4.md) - 2011-12-31 to 2012-12-31 | money | revenue | 8,385,385,000 United States dollar | superseded | [clm_3C7AA6C6D6B9](/claim/clm_3C7AA6C6D6B9.md) - 2011-12-31 to 2012-03-31 | money | total_assets | 17,303,134,000 United States dollar | superseded | [clm_B88E927B540C](/claim/clm_B88E927B540C.md) - 2011-12-31 to 2012-03-31 | money | total_equity | 6,738,856,000 United States dollar | superseded | [clm_019E95D10520](/claim/clm_019E95D10520.md) ## 2012 - 2012-02-10 to 2012-04-27 | money | shares_outstanding | 757,315,361 shares | superseded | [clm_BA2204982948](/claim/clm_BA2204982948.md) - 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 1,451,942,000 United States dollar | superseded | [clm_3E3CA2BE557A](/claim/clm_3E3CA2BE557A.md) - 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 437,531,000 United States dollar | superseded | [clm_F9773DDC0E63](/claim/clm_F9773DDC0E63.md) - 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 800,186,000 United States dollar | superseded | [clm_1B04A7872EB1](/claim/clm_1B04A7872EB1.md) - 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 458,211,000 United States dollar | superseded | [clm_582F2BDA4127](/claim/clm_582F2BDA4127.md) - 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 2,282,449,000 United States dollar | superseded | [clm_EB005128324C](/claim/clm_EB005128324C.md) - 2012-03-31 to 2012-06-30 | money | total_assets | 19,950,386,000 United States dollar | superseded | [clm_5146FDD0A30B](/claim/clm_5146FDD0A30B.md) - 2012-03-31 to 2012-06-30 | money | total_equity | 7,313,612,000 United States dollar | superseded | [clm_F100EC2AA0AB](/claim/clm_F100EC2AA0AB.md) - 2012-04-27 to 2012-07-20 | money | shares_outstanding | 757,321,824 shares | superseded | [clm_0D0B69B94297](/claim/clm_0D0B69B94297.md) - 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 1,625,500,000 United States dollar | superseded | [clm_0819CD93D3BE](/claim/clm_0819CD93D3BE.md) - 2012-06-30 to 2012-09-30 | money | quarterly_net_income | 706,074,000 United States dollar | superseded | [clm_D51703E0CC72](/claim/clm_D51703E0CC72.md) - 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | 1,059,092,000 United States dollar | superseded | [clm_74B44D14A03E](/claim/clm_74B44D14A03E.md) - 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 396,244,000 United States dollar | superseded | [clm_DA658E3C399A](/claim/clm_DA658E3C399A.md) - 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 2,405,186,000 United States dollar | superseded | [clm_FB8DA58174AA](/claim/clm_FB8DA58174AA.md) - 2012-06-30 to 2012-09-30 | money | total_assets | 20,501,950,000 United States dollar | superseded | [clm_35B1D94A76C2](/claim/clm_35B1D94A76C2.md) - 2012-06-30 to 2012-09-30 | money | total_equity | 8,002,120,000 United States dollar | superseded | [clm_67DBD97EDB58](/claim/clm_67DBD97EDB58.md) - 2012-07-20 to 2012-10-26 | money | shares_outstanding | 756,568,507 shares | superseded | [clm_FDFFC4589CCA](/claim/clm_FDFFC4589CCA.md) - 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 1,550,710,000 United States dollar | superseded | [clm_F539577166A9](/claim/clm_F539577166A9.md) - 2012-09-30 to 2013-03-31 | money | quarterly_net_income | 675,505,000 United States dollar | superseded | [clm_B643FBA97A26](/claim/clm_B643FBA97A26.md) - 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 1,043,914,000 United States dollar | superseded | [clm_FA96CB92CE64](/claim/clm_FA96CB92CE64.md) - 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 465,831,000 United States dollar | superseded | [clm_5682E86D49EF](/claim/clm_5682E86D49EF.md) - 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 2,426,597,000 United States dollar | superseded | [clm_B8600EE329E3](/claim/clm_B8600EE329E3.md) - 2012-09-30 to 2012-12-31 | money | total_assets | 20,963,829,000 United States dollar | superseded | [clm_6AA4CA365EAD](/claim/clm_6AA4CA365EAD.md) - 2012-09-30 to 2012-12-31 | money | total_equity | 8,603,642,000 United States dollar | superseded | [clm_E1F92FF8F547](/claim/clm_E1F92FF8F547.md) - 2012-10-26 to 2013-02-15 | money | shares_outstanding | 757,648,151 shares | superseded | [clm_E031E45D588C](/claim/clm_E031E45D588C.md) - 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 1,803,694,000 United States dollar | superseded | [clm_FCBEE31BA577](/claim/clm_FCBEE31BA577.md) - 2012-12-31 to 2013-12-31 | money | net_income | 2,591,566,000 United States dollar | superseded | [clm_9F2904CE8D05](/claim/clm_9F2904CE8D05.md) - 2012-12-31 to 2013-12-31 | money | operating_income | 4,010,175,000 United States dollar | superseded | [clm_A7885EF38F91](/claim/clm_A7885EF38F91.md) - 2012-12-31 to 2013-12-31 | money | research_and_development | 1,759,945,000 United States dollar | superseded | [clm_97DAFF25A056](/claim/clm_97DAFF25A056.md) - 2012-12-31 to 2013-12-31 | money | revenue | 9,702,517,000 United States dollar | superseded | [clm_6D4418F572A9](/claim/clm_6D4418F572A9.md) - 2012-12-31 to 2013-03-31 | money | total_assets | 21,239,838,000 United States dollar | superseded | [clm_15468AB110B1](/claim/clm_15468AB110B1.md) - 2012-12-31 to 2013-03-31 | money | total_equity | 9,309,739,000 United States dollar | superseded | [clm_91959D69DC35](/claim/clm_91959D69DC35.md) ## 2013 - 2013-02-15 to 2013-04-26 | money | shares_outstanding | 1,522,392,518 shares | superseded | [clm_45B915515FE5](/claim/clm_45B915515FE5.md) - 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 1,863,972,000 United States dollar | superseded | [clm_3F890EF44E32](/claim/clm_3F890EF44E32.md) - 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 722,186,000 United States dollar | superseded | [clm_388E2FFF1D4B](/claim/clm_388E2FFF1D4B.md) - 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 1,025,259,000 United States dollar | superseded | [clm_4AB2B075DD45](/claim/clm_4AB2B075DD45.md) - 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 497,632,000 United States dollar | superseded | [clm_4716BEA47C18](/claim/clm_4716BEA47C18.md) - 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 2,531,635,000 United States dollar | superseded | [clm_CF7263DF8433](/claim/clm_CF7263DF8433.md) - 2013-03-31 to 2013-06-30 | money | total_assets | 22,211,668,000 United States dollar | superseded | [clm_58A0E5DA42E6](/claim/clm_58A0E5DA42E6.md) - 2013-03-31 to 2013-06-30 | money | total_equity | 10,152,231,000 United States dollar | superseded | [clm_85F66B9E6C53](/claim/clm_85F66B9E6C53.md) - 2013-04-26 to 2013-07-19 | money | shares_outstanding | 1,525,355,825 shares | superseded | [clm_1D55B20D73A5](/claim/clm_1D55B20D73A5.md) - 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 2,202,176,000 United States dollar | superseded | [clm_2C5E443BE540](/claim/clm_2C5E443BE540.md) - 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 772,605,000 United States dollar | superseded | [clm_89E5E1F0C38A](/claim/clm_89E5E1F0C38A.md) - 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 1,153,838,000 United States dollar | superseded | [clm_E29B9FC01B82](/claim/clm_E29B9FC01B82.md) - 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 523,902,000 United States dollar | superseded | [clm_BEDA44B8703A](/claim/clm_BEDA44B8703A.md) - 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 2,767,394,000 United States dollar | superseded | [clm_D79BF1F1049A](/claim/clm_D79BF1F1049A.md) - 2013-06-30 to 2013-09-30 | money | total_assets | 22,624,374,000 United States dollar | superseded | [clm_4A06B5FD1CCE](/claim/clm_4A06B5FD1CCE.md) - 2013-06-30 to 2013-09-30 | money | total_equity | 11,092,000,000 United States dollar | superseded | [clm_48AE970C35D8](/claim/clm_48AE970C35D8.md) - 2013-07-19 to 2013-10-18 | money | shares_outstanding | 1,530,626,021 shares | superseded | [clm_725CDC55F839](/claim/clm_725CDC55F839.md) - 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 2,010,736,000 United States dollar | superseded | [clm_F25C46B4CD20](/claim/clm_F25C46B4CD20.md) - 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 788,606,000 United States dollar | superseded | [clm_1038E6E3E9FF](/claim/clm_1038E6E3E9FF.md) - 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 1,147,861,000 United States dollar | superseded | [clm_04B6E015FE4D](/claim/clm_04B6E015FE4D.md) - 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 546,244,000 United States dollar | superseded | [clm_C46B94F27B3E](/claim/clm_C46B94F27B3E.md) - 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 2,782,833,000 United States dollar | superseded | [clm_ED3CDE5E3ED7](/claim/clm_ED3CDE5E3ED7.md) - 2013-09-30 to 2013-12-31 | money | total_assets | 22,468,428,000 United States dollar | superseded | [clm_C2B10DAAD114](/claim/clm_C2B10DAAD114.md) - 2013-09-30 to 2013-12-31 | money | total_equity | 10,883,610,000 United States dollar | superseded | [clm_A5E3AA28CA83](/claim/clm_A5E3AA28CA83.md) - 2013-10-18 to 2014-02-14 | money | shares_outstanding | 1,533,349,106 shares | superseded | [clm_9A79DA553882](/claim/clm_9A79DA553882.md) - 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 2,112,806,000 United States dollar | superseded | [clm_6099A9C5C90E](/claim/clm_6099A9C5C90E.md) - 2013-12-31 to 2014-12-31 | money | net_income | 3,074,808,000 United States dollar | superseded | [clm_97D551EB0FC8](/claim/clm_97D551EB0FC8.md) - 2013-12-31 to 2014-12-31 | money | operating_income | 4,523,999,000 United States dollar | superseded | [clm_BC08A5BEA713](/claim/clm_BC08A5BEA713.md) - 2013-12-31 to 2014-12-31 | money | research_and_development | 2,119,756,000 United States dollar | superseded | [clm_A89347762D25](/claim/clm_A89347762D25.md) - 2013-12-31 to 2014-12-31 | money | revenue | 11,201,688,000 United States dollar | superseded | [clm_C43DA4F79044](/claim/clm_C43DA4F79044.md) - 2013-12-31 to 2014-03-31 | money | total_assets | 22,496,785,000 United States dollar | superseded | [clm_E924B4484B29](/claim/clm_E924B4484B29.md) - 2013-12-31 to 2014-03-31 | money | total_equity | 11,369,067,000 United States dollar | superseded | [clm_220CB7E7E545](/claim/clm_220CB7E7E545.md) ## 2014 - 2014-02-14 to 2014-04-25 | money | shares_outstanding | 1,538,252,914 shares | superseded | [clm_76CC3B65DDF7](/claim/clm_76CC3B65DDF7.md) - 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 6,404,153,000 United States dollar | superseded | [clm_9855991F2297](/claim/clm_9855991F2297.md) - 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 2,227,410,000 United States dollar | superseded | [clm_BA19192F9268](/claim/clm_BA19192F9268.md) - 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 3,042,650,000 United States dollar | superseded | [clm_184386B278EF](/claim/clm_184386B278EF.md) - 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 594,978,000 United States dollar | superseded | [clm_7E2A196ABDE1](/claim/clm_7E2A196ABDE1.md) - 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 4,998,956,000 United States dollar | superseded | [clm_890094891137](/claim/clm_890094891137.md) - 2014-03-31 to 2014-06-30 | money | total_assets | 28,077,692,000 United States dollar | superseded | [clm_8216174716E2](/claim/clm_8216174716E2.md) - 2014-03-31 to 2014-06-30 | money | total_equity | 13,387,322,000 United States dollar | superseded | [clm_B07CC2780AF7](/claim/clm_B07CC2780AF7.md) - 2014-04-25 to 2014-07-25 | money | shares_outstanding | 1,535,682,107 shares | superseded | [clm_7AB4B128BE59](/claim/clm_7AB4B128BE59.md) - 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 8,730,522,000 United States dollar | superseded | [clm_401F7ECEA86E](/claim/clm_401F7ECEA86E.md) - 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 3,655,593,000 United States dollar | superseded | [clm_90DDD6E3BE13](/claim/clm_90DDD6E3BE13.md) - 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 4,412,755,000 United States dollar | superseded | [clm_42E6B9EB2E6E](/claim/clm_42E6B9EB2E6E.md) - 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 583,924,000 United States dollar | superseded | [clm_B0CF038E671F](/claim/clm_B0CF038E671F.md) - 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 6,534,943,000 United States dollar | superseded | [clm_9B9748234060](/claim/clm_9B9748234060.md) - 2014-06-30 to 2014-09-30 | money | total_assets | 31,206,164,000 United States dollar | superseded | [clm_073B8D19A679](/claim/clm_073B8D19A679.md) - 2014-06-30 to 2014-09-30 | money | total_equity | 16,090,629,000 United States dollar | superseded | [clm_75A0E5882CB0](/claim/clm_75A0E5882CB0.md) - 2014-07-25 to 2014-10-31 | money | shares_outstanding | 1,511,670,456 shares | superseded | [clm_1541FF3D3905](/claim/clm_1541FF3D3905.md) - 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 6,209,060,000 United States dollar | superseded | [clm_197FF9089D7D](/claim/clm_197FF9089D7D.md) - 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 2,731,274,000 United States dollar | superseded | [clm_2DA8137DB2EA](/claim/clm_2DA8137DB2EA.md) - 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 3,479,223,000 United States dollar | superseded | [clm_796B0D2AB76A](/claim/clm_796B0D2AB76A.md) - 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 630,466,000 United States dollar | superseded | [clm_0BA87D52CC96](/claim/clm_0BA87D52CC96.md) - 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 6,041,832,000 United States dollar | superseded | [clm_DF1ED50540CF](/claim/clm_DF1ED50540CF.md) - 2014-09-30 to 2014-12-31 | money | total_assets | 28,844,393,000 United States dollar | superseded | [clm_7F1BCBD81907](/claim/clm_7F1BCBD81907.md) - 2014-09-30 to 2014-12-31 | money | total_equity | 13,566,223,000 United States dollar | superseded | [clm_77E644719A6A](/claim/clm_77E644719A6A.md) - 2014-10-31 to 2015-02-13 | money | shares_outstanding | 1,508,664,333 shares | superseded | [clm_F1B081019EDB](/claim/clm_F1B081019EDB.md) - 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 10,027,000,000 United States dollar | superseded | [clm_7B67F0C2B7A3](/claim/clm_7B67F0C2B7A3.md) - 2014-12-31 to 2015-12-31 | money | net_income | 12,101,000,000 United States dollar | superseded | [clm_918922602D80](/claim/clm_918922602D80.md) - 2014-12-31 to 2015-12-31 | money | operating_income | 15,265,000,000 United States dollar | superseded | [clm_830AD3CBC862](/claim/clm_830AD3CBC862.md) - 2014-12-31 to 2015-12-31 | money | research_and_development | 2,854,000,000 United States dollar | superseded | [clm_D01DF9FC4DE7](/claim/clm_D01DF9FC4DE7.md) - 2014-12-31 to 2015-12-31 | money | revenue | 24,890,000,000 United States dollar | superseded | [clm_617CC39EB4D4](/claim/clm_617CC39EB4D4.md) - 2014-12-31 to 2015-03-31 | money | total_assets | 34,664,000,000 United States dollar | superseded | [clm_FEBA53BD0180](/claim/clm_FEBA53BD0180.md) - 2014-12-31 to 2015-03-31 | money | total_equity | 15,426,000,000 United States dollar | superseded | [clm_8CF7142E8E33](/claim/clm_8CF7142E8E33.md) ## 2015 - 2015-02-13 to 2015-04-30 | money | shares_outstanding | 1,489,401,683 shares | superseded | [clm_46E3C4C88388](/claim/clm_46E3C4C88388.md) - 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 10,635,000,000 United States dollar | superseded | [clm_6AAA25871D37](/claim/clm_6AAA25871D37.md) - 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 4,333,000,000 United States dollar | superseded | [clm_BC16F61ED0DA](/claim/clm_BC16F61ED0DA.md) - 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 5,371,000,000 United States dollar | superseded | [clm_8B847A3897B8](/claim/clm_8B847A3897B8.md) - 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 696,000,000 United States dollar | superseded | [clm_C007A487B9D0](/claim/clm_C007A487B9D0.md) - 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 7,594,000,000 United States dollar | superseded | [clm_4B94008EAEAA](/claim/clm_4B94008EAEAA.md) - 2015-03-31 to 2015-06-30 | money | total_assets | 38,321,000,000 United States dollar | superseded | [clm_140D00598977](/claim/clm_140D00598977.md) - 2015-03-31 to 2015-06-30 | money | total_equity | 17,180,000,000 United States dollar | superseded | [clm_71908216DDFE](/claim/clm_71908216DDFE.md) - 2015-04-30 to 2015-07-31 | money | shares_outstanding | 1,469,605,980 shares | superseded | [clm_D5531C297C82](/claim/clm_D5531C297C82.md) - 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 7,417,000,000 United States dollar | superseded | [clm_60E4DC378174](/claim/clm_60E4DC378174.md) - 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 4,492,000,000 United States dollar | superseded | [clm_DF79C5D89594](/claim/clm_DF79C5D89594.md) - 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 5,616,000,000 United States dollar | superseded | [clm_3B528F1C96CB](/claim/clm_3B528F1C96CB.md) - 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 818,000,000 United States dollar | superseded | [clm_BD4CAF70327B](/claim/clm_BD4CAF70327B.md) - 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 8,244,000,000 United States dollar | superseded | [clm_B77960C40400](/claim/clm_B77960C40400.md) - 2015-06-30 to 2015-09-30 | money | total_assets | 39,167,000,000 United States dollar | superseded | [clm_C59C0F08C1D6](/claim/clm_C59C0F08C1D6.md) - 2015-06-30 to 2015-09-30 | money | total_equity | 16,287,000,000 United States dollar | superseded | [clm_EA7023B67827](/claim/clm_EA7023B67827.md) - 2015-07-31 to 2015-10-30 | money | shares_outstanding | 1,467,605,502 shares | superseded | [clm_276D7713D95E](/claim/clm_276D7713D95E.md) - 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 13,965,000,000 United States dollar | superseded | [clm_E121FF6F1BD4](/claim/clm_E121FF6F1BD4.md) - 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 4,600,000,000 United States dollar | superseded | [clm_B60BC536C441](/claim/clm_B60BC536C441.md) - 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 5,585,000,000 United States dollar | superseded | [clm_5C3945CA6EA3](/claim/clm_5C3945CA6EA3.md) - 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 743,000,000 United States dollar | superseded | [clm_86055E0F3919](/claim/clm_86055E0F3919.md) - 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 8,295,000,000 United States dollar | superseded | [clm_1FCA56C9FDDA](/claim/clm_1FCA56C9FDDA.md) - 2015-09-30 to 2015-12-31 | money | total_assets | 50,637,000,000 United States dollar | superseded | [clm_53DDA1B5667A](/claim/clm_53DDA1B5667A.md) - 2015-09-30 to 2015-12-31 | money | total_equity | 17,414,000,000 United States dollar | superseded | [clm_71BC7C11F77A](/claim/clm_71BC7C11F77A.md) - 2015-10-30 to 2016-02-12 | money | shares_outstanding | 1,441,180,186 shares | superseded | [clm_5B012B612E72](/claim/clm_5B012B612E72.md) - 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 12,851,000,000 United States dollar | superseded | [clm_F514161AC740](/claim/clm_F514161AC740.md) - 2015-12-31 to 2016-12-31 | money | net_income | 18,108,000,000 United States dollar | superseded | [clm_E1EF723628E4](/claim/clm_E1EF723628E4.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 22,193,000,000 United States dollar | superseded | [clm_3CA462AADF8A](/claim/clm_3CA462AADF8A.md) - 2015-12-31 to 2016-12-31 | money | research_and_development | 3,014,000,000 United States dollar | superseded | [clm_C611C725BFCF](/claim/clm_C611C725BFCF.md) - 2015-12-31 to 2016-12-31 | money | revenue | 32,639,000,000 United States dollar | superseded | [clm_963EB0743197](/claim/clm_963EB0743197.md) - 2015-12-31 to 2016-03-31 | money | total_assets | 51,839,000,000 United States dollar | superseded | [clm_D56AF049FD72](/claim/clm_D56AF049FD72.md) - 2015-12-31 to 2016-03-31 | money | total_equity | 18,534,000,000 United States dollar | superseded | [clm_27F3DD63E611](/claim/clm_27F3DD63E611.md) ## 2016 - 2016-02-12 to 2016-04-29 | money | shares_outstanding | 1,366,845,691 shares | superseded | [clm_7B29D67F521F](/claim/clm_7B29D67F521F.md) - 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 6,315,000,000 United States dollar | superseded | [clm_2CF37CEBBBB9](/claim/clm_2CF37CEBBBB9.md) - 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 3,566,000,000 United States dollar | superseded | [clm_85B2D6656C9A](/claim/clm_85B2D6656C9A.md) - 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 4,651,000,000 United States dollar | superseded | [clm_3C1AA086404C](/claim/clm_3C1AA086404C.md) - 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 1,265,000,000 United States dollar | superseded | [clm_4A46A41D0E94](/claim/clm_4A46A41D0E94.md) - 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 7,794,000,000 United States dollar | superseded | [clm_78CFE1D6629B](/claim/clm_78CFE1D6629B.md) - 2016-03-31 to 2016-06-30 | money | total_assets | 47,765,000,000 United States dollar | superseded | [clm_DA37C019E024](/claim/clm_DA37C019E024.md) - 2016-03-31 to 2016-06-30 | money | total_equity | 13,398,000,000 United States dollar | superseded | [clm_5C721A2A8DF5](/claim/clm_5C721A2A8DF5.md) - 2016-04-29 to 2016-07-31 | money | shares_outstanding | 1,331,821,506 shares | superseded | [clm_CE80F4959ACE](/claim/clm_CE80F4959ACE.md) - 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 6,485,000,000 United States dollar | superseded | [clm_08545099492F](/claim/clm_08545099492F.md) - 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 3,497,000,000 United States dollar | superseded | [clm_12950DB90363](/claim/clm_12950DB90363.md) - 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 4,538,000,000 United States dollar | superseded | [clm_26F557F5D548](/claim/clm_26F557F5D548.md) - 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 1,484,000,000 United States dollar | superseded | [clm_2114180CCC8B](/claim/clm_2114180CCC8B.md) - 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 7,776,000,000 United States dollar | superseded | [clm_CC9217F333A8](/claim/clm_CC9217F333A8.md) - 2016-06-30 to 2016-09-30 | money | total_assets | 49,980,000,000 United States dollar | superseded | [clm_EC34211A91A5](/claim/clm_EC34211A91A5.md) - 2016-06-30 to 2016-09-30 | money | total_equity | 15,536,000,000 United States dollar | superseded | [clm_A37712B935A5](/claim/clm_A37712B935A5.md) - 2016-07-31 to 2016-10-31 | money | shares_outstanding | 1,319,658,489 shares | superseded | [clm_0540BDF9635D](/claim/clm_0540BDF9635D.md) - 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 9,809,000,000 United States dollar | superseded | [clm_E971A4A44267](/claim/clm_E971A4A44267.md) - 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 3,330,000,000 United States dollar | superseded | [clm_6462A95E705D](/claim/clm_6462A95E705D.md) - 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 4,399,000,000 United States dollar | superseded | [clm_6416AB6D896A](/claim/clm_6416AB6D896A.md) - 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 1,141,000,000 United States dollar | superseded | [clm_7055B95F726C](/claim/clm_7055B95F726C.md) - 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 7,500,000,000 United States dollar | superseded | [clm_E2545AE7F426](/claim/clm_E2545AE7F426.md) - 2016-09-30 to 2016-12-31 | money | total_assets | 56,609,000,000 United States dollar | superseded | [clm_EE2C45744700](/claim/clm_EE2C45744700.md) - 2016-09-30 to 2016-12-31 | money | total_equity | 16,868,000,000 United States dollar | superseded | [clm_4343230CB05B](/claim/clm_4343230CB05B.md) - 2016-10-31 to 2017-02-16 | money | shares_outstanding | 1,317,456,071 shares | superseded | [clm_4226A2D9D3FB](/claim/clm_4226A2D9D3FB.md) - 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 8,229,000,000 United States dollar | superseded | [clm_990E09396E1F](/claim/clm_990E09396E1F.md) - 2016-12-31 to 2017-12-31 | money | net_income | 13,501,000,000 United States dollar | superseded | [clm_ACDE59759096](/claim/clm_ACDE59759096.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 17,633,000,000 United States dollar | superseded | [clm_69A3F1EE9840](/claim/clm_69A3F1EE9840.md) - 2016-12-31 to 2017-12-31 | money | research_and_development | 5,098,000,000 United States dollar | superseded | [clm_A135DBE0E85A](/claim/clm_A135DBE0E85A.md) - 2016-12-31 to 2017-12-31 | money | revenue | 30,390,000,000 United States dollar | superseded | [clm_FC87519132B6](/claim/clm_FC87519132B6.md) - 2016-12-31 to 2017-03-31 | money | total_assets | 56,977,000,000 United States dollar | superseded | [clm_976C69D91B06](/claim/clm_976C69D91B06.md) - 2016-12-31 to 2017-03-31 | money | total_equity | 18,887,000,000 United States dollar | superseded | [clm_9015437E803C](/claim/clm_9015437E803C.md) ## 2017 - 2017-02-16 to 2017-04-28 | money | shares_outstanding | 1,307,066,900 shares | superseded | [clm_D33C40190158](/claim/clm_D33C40190158.md) - 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 10,285,000,000 United States dollar | superseded | [clm_A199458E8799](/claim/clm_A199458E8799.md) - 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 2,702,000,000 United States dollar | superseded | [clm_08B75807F50B](/claim/clm_08B75807F50B.md) - 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 3,767,000,000 United States dollar | superseded | [clm_36523E1DC403](/claim/clm_36523E1DC403.md) - 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 931,000,000 United States dollar | superseded | [clm_AD7234D455A7](/claim/clm_AD7234D455A7.md) - 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 6,505,000,000 United States dollar | superseded | [clm_2C565010AFA4](/claim/clm_2C565010AFA4.md) - 2017-03-31 to 2017-06-30 | money | total_assets | 57,701,000,000 United States dollar | superseded | [clm_DCE9F3C6B7BD](/claim/clm_DCE9F3C6B7BD.md) - 2017-03-31 to 2017-06-30 | money | total_equity | 20,441,000,000 United States dollar | superseded | [clm_B888594CFA0B](/claim/clm_B888594CFA0B.md) - 2017-04-28 to 2017-07-31 | money | shares_outstanding | 1,306,728,398 shares | superseded | [clm_D1A23A561B3B](/claim/clm_D1A23A561B3B.md) - 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 8,712,000,000 United States dollar | superseded | [clm_FB17AC864D9C](/claim/clm_FB17AC864D9C.md) - 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 3,073,000,000 United States dollar | superseded | [clm_359D7E1B8020](/claim/clm_359D7E1B8020.md) - 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 4,254,000,000 United States dollar | superseded | [clm_079E4DCAAED6](/claim/clm_079E4DCAAED6.md) - 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 864,000,000 United States dollar | superseded | [clm_3137B2FCB357](/claim/clm_3137B2FCB357.md) - 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 7,141,000,000 United States dollar | superseded | [clm_36D2C5AC16C0](/claim/clm_36D2C5AC16C0.md) - 2017-06-30 to 2017-09-30 | money | total_assets | 60,263,000,000 United States dollar | superseded | [clm_C0F22A4ECEE7](/claim/clm_C0F22A4ECEE7.md) - 2017-06-30 to 2017-09-30 | money | total_equity | 22,677,000,000 United States dollar | superseded | [clm_71AAC35B0398](/claim/clm_71AAC35B0398.md) - 2017-07-31 to 2017-10-31 | money | shares_outstanding | 1,305,926,217 shares | superseded | [clm_5F1621F78102](/claim/clm_5F1621F78102.md) - 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 11,508,000,000 United States dollar | superseded | [clm_6553928A4F4E](/claim/clm_6553928A4F4E.md) - 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 2,718,000,000 United States dollar | superseded | [clm_74BBE0739D9C](/claim/clm_74BBE0739D9C.md) - 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 3,812,000,000 United States dollar | superseded | [clm_658A565141FB](/claim/clm_658A565141FB.md) - 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 789,000,000 United States dollar | superseded | [clm_C314071CED94](/claim/clm_C314071CED94.md) - 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 6,512,000,000 United States dollar | superseded | [clm_5093D8587F37](/claim/clm_5093D8587F37.md) - 2017-09-30 to 2017-12-31 | money | total_assets | 64,662,000,000 United States dollar | superseded | [clm_94616F3E1AEA](/claim/clm_94616F3E1AEA.md) - 2017-09-30 to 2017-12-31 | money | total_equity | 24,845,000,000 United States dollar | superseded | [clm_7E2E193AAECA](/claim/clm_7E2E193AAECA.md) - 2017-10-31 to 2018-02-15 | money | shares_outstanding | 1,306,268,996 shares | superseded | [clm_CF2D067A89F6](/claim/clm_CF2D067A89F6.md) - 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 7,588,000,000 United States dollar | superseded | [clm_60315DE617E0](/claim/clm_60315DE617E0.md) - 2017-12-31 to 2018-12-31 | money | net_income | 4,628,000,000 United States dollar | superseded | [clm_E7E834C64911](/claim/clm_E7E834C64911.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 14,124,000,000 United States dollar | superseded | [clm_757554EF6848](/claim/clm_757554EF6848.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 3,734,000,000 United States dollar | superseded | [clm_F57660C96CD5](/claim/clm_F57660C96CD5.md) - 2017-12-31 to 2018-12-31 | money | revenue | 26,107,000,000 United States dollar | superseded | [clm_27E7D83B62B4](/claim/clm_27E7D83B62B4.md) - 2017-12-31 to 2018-03-31 | money | total_assets | 70,283,000,000 United States dollar | superseded | [clm_CBC8CA566644](/claim/clm_CBC8CA566644.md) - 2017-12-31 to 2018-03-31 | money | total_equity | 20,442,000,000 United States dollar | superseded | [clm_58599489AE93](/claim/clm_58599489AE93.md) ## 2018 - 2018-02-15 to 2018-04-30 | money | shares_outstanding | 1,309,967,781 shares | superseded | [clm_404C97BD98A7](/claim/clm_404C97BD98A7.md) - 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 7,643,000,000 United States dollar | superseded | [clm_3B5A1FA2D337](/claim/clm_3B5A1FA2D337.md) - 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 1,538,000,000 United States dollar | superseded | [clm_AAB4DD2B4052](/claim/clm_AAB4DD2B4052.md) - 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 2,153,000,000 United States dollar | superseded | [clm_E8767F1F6334](/claim/clm_E8767F1F6334.md) - 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 937,000,000 United States dollar | superseded | [clm_BADB05CE1396](/claim/clm_BADB05CE1396.md) - 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 5,088,000,000 United States dollar | superseded | [clm_60A396F25E49](/claim/clm_60A396F25E49.md) - 2018-03-31 to 2018-06-30 | money | total_assets | 65,381,000,000 United States dollar | superseded | [clm_B7A025B4E972](/claim/clm_B7A025B4E972.md) - 2018-03-31 to 2018-06-30 | money | total_equity | 20,591,000,000 United States dollar | superseded | [clm_FC73834F60CC](/claim/clm_FC73834F60CC.md) - 2018-04-30 to 2018-07-30 | money | shares_outstanding | 1,300,260,832 shares | superseded | [clm_A4949CF68D82](/claim/clm_A4949CF68D82.md) - 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 13,234,000,000 United States dollar | superseded | [clm_327B4DC1B791](/claim/clm_327B4DC1B791.md) - 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 1,817,000,000 United States dollar | superseded | [clm_FD40C1416217](/claim/clm_FD40C1416217.md) - 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 2,280,000,000 United States dollar | superseded | [clm_C34C93C7683D](/claim/clm_C34C93C7683D.md) - 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 1,192,000,000 United States dollar | superseded | [clm_E1F6AE4E3122](/claim/clm_E1F6AE4E3122.md) - 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 5,648,000,000 United States dollar | superseded | [clm_F8567009A977](/claim/clm_F8567009A977.md) - 2018-06-30 to 2018-09-30 | money | total_assets | 65,355,000,000 United States dollar | superseded | [clm_45E4E089CC81](/claim/clm_45E4E089CC81.md) - 2018-06-30 to 2018-09-30 | money | total_equity | 21,672,000,000 United States dollar | superseded | [clm_30747CB3FFA8](/claim/clm_30747CB3FFA8.md) - 2018-07-30 to 2018-10-30 | money | shares_outstanding | 1,296,340,593 shares | superseded | [clm_E80445428580](/claim/clm_E80445428580.md) - 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 14,569,000,000 United States dollar | superseded | [clm_C97C95BA7944](/claim/clm_C97C95BA7944.md) - 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 2,097,000,000 United States dollar | superseded | [clm_4163B40D60DC](/claim/clm_4163B40D60DC.md) - 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 2,623,000,000 United States dollar | superseded | [clm_F552A8FA3730](/claim/clm_F552A8FA3730.md) - 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 939,000,000 United States dollar | superseded | [clm_914CFB3695E1](/claim/clm_914CFB3695E1.md) - 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 5,596,000,000 United States dollar | superseded | [clm_1F83C4577253](/claim/clm_1F83C4577253.md) - 2018-09-30 to 2018-12-31 | money | total_assets | 64,305,000,000 United States dollar | superseded | [clm_6208207FCA1C](/claim/clm_6208207FCA1C.md) - 2018-09-30 to 2018-12-31 | money | total_equity | 22,861,000,000 United States dollar | superseded | [clm_EB6EC79E44BE](/claim/clm_EB6EC79E44BE.md) - 2018-10-30 to 2019-02-15 | money | shares_outstanding | 1,293,619,612 shares | superseded | [clm_9310E67C75CD](/claim/clm_9310E67C75CD.md) - 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 17,940,000,000 United States dollar | superseded | [clm_84B3E38A3786](/claim/clm_84B3E38A3786.md) - 2018-12-31 to 2019-12-31 | money | net_income | 5,455,000,000 United States dollar | superseded | [clm_F6D84B82A4B7](/claim/clm_F6D84B82A4B7.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 8,200,000,000 United States dollar | superseded | [clm_4AC1B328D986](/claim/clm_4AC1B328D986.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 5,018,000,000 United States dollar | superseded | [clm_A4D93ABC998F](/claim/clm_A4D93ABC998F.md) - 2018-12-31 to 2019-12-31 | money | revenue | 22,127,000,000 United States dollar | superseded | [clm_2C70360428CB](/claim/clm_2C70360428CB.md) - 2018-12-31 to 2019-03-31 | money | total_assets | 63,675,000,000 United States dollar | superseded | [clm_F8D980C66571](/claim/clm_F8D980C66571.md) - 2018-12-31 to 2019-03-31 | money | total_equity | 21,387,000,000 United States dollar | superseded | [clm_01DEEAA7959E](/claim/clm_01DEEAA7959E.md) ## 2019 - 2019-02-15 to 2019-04-30 | money | shares_outstanding | 1,275,510,558 shares | superseded | [clm_64804BC6C18F](/claim/clm_64804BC6C18F.md) - 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 16,927,000,000 United States dollar | superseded | [clm_BEC694801E94](/claim/clm_BEC694801E94.md) - 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 1,975,000,000 United States dollar | superseded | [clm_981215B6D1DE](/claim/clm_981215B6D1DE.md) - 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 2,237,000,000 United States dollar | superseded | [clm_304B07F7B38F](/claim/clm_304B07F7B38F.md) - 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 1,057,000,000 United States dollar | superseded | [clm_D532699D7671](/claim/clm_D532699D7671.md) - 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 5,281,000,000 United States dollar | superseded | [clm_E4C5A9D23585](/claim/clm_E4C5A9D23585.md) - 2019-03-31 to 2019-06-30 | money | total_assets | 62,837,000,000 United States dollar | superseded | [clm_7C0CBF1B6C32](/claim/clm_7C0CBF1B6C32.md) - 2019-03-31 to 2019-06-30 | money | total_equity | 21,951,000,000 United States dollar | superseded | [clm_427FE77026B1](/claim/clm_427FE77026B1.md) - 2019-04-30 to 2019-07-30 | money | shares_outstanding | 1,271,554,672 shares | superseded | [clm_55FF6D3BF284](/claim/clm_55FF6D3BF284.md) - 2019-06-30 to 2019-12-31 | money | cash_and_equivalents | 11,240,000,000 United States dollar | superseded | [clm_6F4EA3581211](/claim/clm_6F4EA3581211.md) - 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 1,880,000,000 United States dollar | superseded | [clm_930129505748](/claim/clm_930129505748.md) - 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 2,430,000,000 United States dollar | superseded | [clm_6CBC8FA47C02](/claim/clm_6CBC8FA47C02.md) - 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 1,160,000,000 United States dollar | superseded | [clm_56C675C78488](/claim/clm_56C675C78488.md) - 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 5,685,000,000 United States dollar | superseded | [clm_57A874E5A2DF](/claim/clm_57A874E5A2DF.md) - 2019-06-30 to 2019-09-30 | money | total_assets | 63,210,000,000 United States dollar | superseded | [clm_C442F5426531](/claim/clm_C442F5426531.md) - 2019-06-30 to 2019-09-30 | money | total_equity | 22,616,000,000 United States dollar | superseded | [clm_9BD72894A2FA](/claim/clm_9BD72894A2FA.md) - 2019-07-30 to 2019-10-29 | money | shares_outstanding | 1,266,455,481 shares | superseded | [clm_A594D1759806](/claim/clm_A594D1759806.md) - 2019-09-30 to 2020-03-31 | money | quarterly_net_income | -1,165,000,000 United States dollar | superseded | [clm_1E58DF837507](/claim/clm_1E58DF837507.md) - 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | -1,473,000,000 United States dollar | superseded | [clm_C8C1E348455A](/claim/clm_C8C1E348455A.md) - 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 4,990,000,000 United States dollar | superseded | [clm_2BA275917569](/claim/clm_2BA275917569.md) - 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 5,604,000,000 United States dollar | superseded | [clm_EF8E4AC29278](/claim/clm_EF8E4AC29278.md) - 2019-09-30 to 2019-12-31 | money | total_assets | 59,146,000,000 United States dollar | superseded | [clm_D7E17CBC3EB3](/claim/clm_D7E17CBC3EB3.md) - 2019-09-30 to 2019-12-31 | money | total_equity | 20,604,000,000 United States dollar | superseded | [clm_30E506D439CD](/claim/clm_30E506D439CD.md) - 2019-10-29 to 2020-02-18 | money | shares_outstanding | 1,265,145,612 shares | superseded | [clm_6B1F9AD01EEC](/claim/clm_6B1F9AD01EEC.md) - 2019-12-31 to 2020-12-31 | money | cash_and_equivalents | 11,631,000,000 United States dollar | superseded | [clm_0E1C61435482](/claim/clm_0E1C61435482.md) - 2019-12-31 to 2020-12-31 | money | net_income | 5,386,000,000 United States dollar | superseded | [clm_E9B23117B9AF](/claim/clm_E9B23117B9AF.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 4,287,000,000 United States dollar | superseded | [clm_023882052B6B](/claim/clm_023882052B6B.md) - 2019-12-31 | money | research_and_development | 9,106,000,000 United States dollar | valid | [clm_EF2F795524C5](/claim/clm_EF2F795524C5.md) - 2019-12-31 to 2020-12-31 | money | revenue | 22,449,000,000 United States dollar | superseded | [clm_43120E77E428](/claim/clm_43120E77E428.md) - 2019-12-31 to 2020-03-31 | money | total_assets | 61,627,000,000 United States dollar | superseded | [clm_02108FE6FC36](/claim/clm_02108FE6FC36.md) - 2019-12-31 to 2020-03-31 | money | total_equity | 22,525,000,000 United States dollar | superseded | [clm_82B29CB8F647](/claim/clm_82B29CB8F647.md) ## 2020 - 2020-02-18 to 2020-04-30 | money | shares_outstanding | 1,263,636,656 shares | superseded | [clm_12B84D5C13CF](/claim/clm_12B84D5C13CF.md) - 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 1,551,000,000 United States dollar | superseded | [clm_E6DF670C65F1](/claim/clm_E6DF670C65F1.md) - 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 2,402,000,000 United States dollar | superseded | [clm_C484B0E46708](/claim/clm_C484B0E46708.md) - 2020-03-31 | money | quarterly_research_and_development | 1,101,000,000 United States dollar | valid | [clm_46B555B900FF](/claim/clm_46B555B900FF.md) - 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 5,548,000,000 United States dollar | superseded | [clm_6E06E702C841](/claim/clm_6E06E702C841.md) - 2020-03-31 to 2020-06-30 | money | total_assets | 59,741,000,000 United States dollar | superseded | [clm_8CDEFAE4FDAA](/claim/clm_8CDEFAE4FDAA.md) - 2020-03-31 to 2020-06-30 | money | total_equity | 22,067,000,000 United States dollar | superseded | [clm_E1D334CD57DC](/claim/clm_E1D334CD57DC.md) - 2020-04-30 to 2020-07-31 | money | shares_outstanding | 1,254,373,400 shares | superseded | [clm_422B393AA321](/claim/clm_422B393AA321.md) - 2020-06-30 to 2020-09-30 | money | quarterly_net_income | -3,339,000,000 United States dollar | superseded | [clm_861B89AF3C43](/claim/clm_861B89AF3C43.md) - 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | -2,983,000,000 United States dollar | superseded | [clm_3E90EE434813](/claim/clm_3E90EE434813.md) - 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 5,143,000,000 United States dollar | superseded | [clm_1ACA29BAAAE0](/claim/clm_1ACA29BAAAE0.md) - 2020-06-30 to 2020-09-30 | money | total_assets | 55,934,000,000 United States dollar | superseded | [clm_A09500CBC958](/claim/clm_A09500CBC958.md) - 2020-06-30 to 2020-09-30 | money | total_equity | 18,027,000,000 United States dollar | superseded | [clm_48BA86C58B18](/claim/clm_48BA86C58B18.md) - 2020-07-31 to 2020-10-30 | money | shares_outstanding | 1,253,724,370 shares | superseded | [clm_F01E60E4BBB6](/claim/clm_F01E60E4BBB6.md) - 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 360,000,000 United States dollar | superseded | [clm_7F3A59E84FB2](/claim/clm_7F3A59E84FB2.md) - 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 2,001,000,000 United States dollar | superseded | [clm_6D1C97E6B8EE](/claim/clm_6D1C97E6B8EE.md) - 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 6,577,000,000 United States dollar | superseded | [clm_5E833A6DE889](/claim/clm_5E833A6DE889.md) - 2020-09-30 to 2020-12-31 | money | total_assets | 60,878,000,000 United States dollar | superseded | [clm_2831E2519483](/claim/clm_2831E2519483.md) - 2020-09-30 to 2020-12-31 | money | total_equity | 17,445,000,000 United States dollar | superseded | [clm_33B63987BE41](/claim/clm_33B63987BE41.md) - 2020-10-30 to 2021-02-18 | money | shares_outstanding | 1,253,528,149 shares | superseded | [clm_CBA1F6B8ED24](/claim/clm_CBA1F6B8ED24.md) - 2020-12-31 to 2021-12-31 | money | cash_and_equivalents | 5,997,000,000 United States dollar | superseded | [clm_9D3C6259FA1C](/claim/clm_9D3C6259FA1C.md) - 2020-12-31 to 2021-12-31 | money | net_income | 123,000,000 United States dollar | superseded | [clm_BAAD13DDEE58](/claim/clm_BAAD13DDEE58.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 4,071,000,000 United States dollar | superseded | [clm_371075143050](/claim/clm_371075143050.md) - 2020-12-31 to 2021-12-31 | money | revenue | 24,689,000,000 United States dollar | superseded | [clm_BCA2F683C1DE](/claim/clm_BCA2F683C1DE.md) - 2020-12-31 to 2021-03-31 | money | total_assets | 68,407,000,000 United States dollar | superseded | [clm_F6DE64E9963C](/claim/clm_F6DE64E9963C.md) - 2020-12-31 to 2021-03-31 | money | total_equity | 18,202,000,000 United States dollar | superseded | [clm_1E9CDD4692C6](/claim/clm_1E9CDD4692C6.md) ## 2021 - 2021-02-18 to 2021-04-30 | money | shares_outstanding | 1,256,593,156 shares | superseded | [clm_9574C3BBD817](/claim/clm_9574C3BBD817.md) - 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 1,729,000,000 United States dollar | superseded | [clm_4C823B39A502](/claim/clm_4C823B39A502.md) - 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 2,890,000,000 United States dollar | superseded | [clm_1B217E0A1C39](/claim/clm_1B217E0A1C39.md) - 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 6,423,000,000 United States dollar | superseded | [clm_C2B19AF3DC0B](/claim/clm_C2B19AF3DC0B.md) - 2021-03-31 to 2021-06-30 | money | total_assets | 67,492,000,000 United States dollar | superseded | [clm_14A44F8EE7B7](/claim/clm_14A44F8EE7B7.md) - 2021-03-31 to 2021-06-30 | money | total_equity | 18,952,000,000 United States dollar | superseded | [clm_19A157E5E599](/claim/clm_19A157E5E599.md) - 2021-04-30 to 2021-07-30 | money | shares_outstanding | 1,254,178,166 shares | superseded | [clm_DB0A15F124B7](/claim/clm_DB0A15F124B7.md) - 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 1,522,000,000 United States dollar | superseded | [clm_1E4391435E59](/claim/clm_1E4391435E59.md) - 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 2,246,000,000 United States dollar | superseded | [clm_AF92F29DEEC7](/claim/clm_AF92F29DEEC7.md) - 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 6,217,000,000 United States dollar | superseded | [clm_62C48A7DBB68](/claim/clm_62C48A7DBB68.md) - 2021-06-30 to 2021-09-30 | money | total_assets | 67,984,000,000 United States dollar | superseded | [clm_AE9CA8B5FEB8](/claim/clm_AE9CA8B5FEB8.md) - 2021-06-30 to 2021-09-30 | money | total_equity | 19,703,000,000 United States dollar | superseded | [clm_217A2416EF41](/claim/clm_217A2416EF41.md) - 2021-07-30 to 2021-10-29 | money | shares_outstanding | 1,253,809,440 shares | superseded | [clm_F700D9C680AB](/claim/clm_F700D9C680AB.md) - 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 2,592,000,000 United States dollar | superseded | [clm_25811D4BA2CF](/claim/clm_25811D4BA2CF.md) - 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 3,842,000,000 United States dollar | superseded | [clm_7DE0B9D2BDB0](/claim/clm_7DE0B9D2BDB0.md) - 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 7,421,000,000 United States dollar | superseded | [clm_19619F47A018](/claim/clm_19619F47A018.md) - 2021-09-30 to 2021-12-31 | money | total_assets | 67,098,000,000 United States dollar | superseded | [clm_1FFACD8ACFEC](/claim/clm_1FFACD8ACFEC.md) - 2021-09-30 to 2021-12-31 | money | total_equity | 21,470,000,000 United States dollar | superseded | [clm_2D8E14863B08](/claim/clm_2D8E14863B08.md) - 2021-10-29 to 2022-02-18 | money | shares_outstanding | 1,254,383,522 shares | superseded | [clm_35E68D12C487](/claim/clm_35E68D12C487.md) - 2021-12-31 to 2022-12-31 | money | cash_and_equivalents | 5,338,000,000 United States dollar | superseded | [clm_64A5CDC8438B](/claim/clm_64A5CDC8438B.md) - 2021-12-31 to 2022-12-31 | money | net_income | 6,225,000,000 United States dollar | superseded | [clm_C45AC1BEB9A4](/claim/clm_C45AC1BEB9A4.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 9,918,000,000 United States dollar | superseded | [clm_C535F4EBB92C](/claim/clm_C535F4EBB92C.md) - 2021-12-31 to 2022-12-31 | money | revenue | 27,305,000,000 United States dollar | superseded | [clm_D6C1A036D30A](/claim/clm_D6C1A036D30A.md) - 2021-12-31 to 2022-03-31 | money | total_assets | 67,952,000,000 United States dollar | superseded | [clm_081201354DBD](/claim/clm_081201354DBD.md) - 2021-12-31 to 2022-03-31 | money | total_equity | 21,069,000,000 United States dollar | superseded | [clm_747FB329FEC7](/claim/clm_747FB329FEC7.md) ## 2022 - 2022-02-18 to 2022-04-29 | money | shares_outstanding | 1,253,886,724 shares | superseded | [clm_2AF6C073F7F8](/claim/clm_2AF6C073F7F8.md) - 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 19,000,000 United States dollar | superseded | [clm_B63753C50038](/claim/clm_B63753C50038.md) - 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 197,000,000 United States dollar | superseded | [clm_8BA86AE5EFB2](/claim/clm_8BA86AE5EFB2.md) - 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 6,590,000,000 United States dollar | superseded | [clm_43A0A904B6D6](/claim/clm_43A0A904B6D6.md) - 2022-03-31 to 2022-06-30 | money | total_assets | 63,080,000,000 United States dollar | superseded | [clm_DEF79188C6E2](/claim/clm_DEF79188C6E2.md) - 2022-03-31 to 2022-06-30 | money | total_equity | 19,927,000,000 United States dollar | superseded | [clm_04055A7D0B36](/claim/clm_04055A7D0B36.md) - 2022-04-29 to 2022-07-29 | money | shares_outstanding | 1,254,313,448 shares | superseded | [clm_2508959DB71E](/claim/clm_2508959DB71E.md) - 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 1,144,000,000 United States dollar | superseded | [clm_BCC35251681F](/claim/clm_BCC35251681F.md) - 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 2,029,000,000 United States dollar | superseded | [clm_8373F49F9F4A](/claim/clm_8373F49F9F4A.md) - 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 6,260,000,000 United States dollar | superseded | [clm_DAC30FE4D631](/claim/clm_DAC30FE4D631.md) - 2022-06-30 to 2022-09-30 | money | total_assets | 62,870,000,000 United States dollar | superseded | [clm_D9A309C9ADEC](/claim/clm_D9A309C9ADEC.md) - 2022-06-30 to 2022-09-30 | money | total_equity | 20,236,000,000 United States dollar | superseded | [clm_C2489C029177](/claim/clm_C2489C029177.md) - 2022-07-29 to 2022-10-31 | money | shares_outstanding | 1,253,367,394 shares | superseded | [clm_4E0A628F0E89](/claim/clm_4E0A628F0E89.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 1,789,000,000 United States dollar | superseded | [clm_FE7757875B59](/claim/clm_FE7757875B59.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 2,837,000,000 United States dollar | superseded | [clm_AFE437797FF5](/claim/clm_AFE437797FF5.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 7,042,000,000 United States dollar | superseded | [clm_FB8452B2152F](/claim/clm_FB8452B2152F.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 62,557,000,000 United States dollar | superseded | [clm_D40D37E7611A](/claim/clm_D40D37E7611A.md) - 2022-09-30 to 2022-12-31 | money | total_equity | 21,081,000,000 United States dollar | superseded | [clm_2FD264F5993C](/claim/clm_2FD264F5993C.md) - 2022-10-31 to 2023-02-17 | money | shares_outstanding | 1,254,243,845 shares | superseded | [clm_66357F3D3F64](/claim/clm_66357F3D3F64.md) - 2022-12-31 | money | cash_and_equivalents | 5,412,000,000 United States dollar | valid | [clm_7B68B20F3E17](/claim/clm_7B68B20F3E17.md) - 2022-12-31 to 2023-12-31 | money | net_income | 4,592,000,000 United States dollar | superseded | [clm_5E875C84FD17](/claim/clm_5E875C84FD17.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 7,330,000,000 United States dollar | superseded | [clm_1850599904BE](/claim/clm_1850599904BE.md) - 2022-12-31 to 2023-12-31 | money | revenue | 27,281,000,000 United States dollar | superseded | [clm_63D857B5C382](/claim/clm_63D857B5C382.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 63,171,000,000 United States dollar | superseded | [clm_46F0FD922BCD](/claim/clm_46F0FD922BCD.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 21,240,000,000 United States dollar | superseded | [clm_9F042AE98A38](/claim/clm_9F042AE98A38.md) ## 2023 - 2023-02-17 to 2023-04-28 | money | shares_outstanding | 1,247,105,154 shares | superseded | [clm_0E722F0B4CD6](/claim/clm_0E722F0B4CD6.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 1,010,000,000 United States dollar | superseded | [clm_EC8C36049672](/claim/clm_EC8C36049672.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 1,705,000,000 United States dollar | superseded | [clm_3745B13B8F94](/claim/clm_3745B13B8F94.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 6,352,000,000 United States dollar | superseded | [clm_2124B66E70B5](/claim/clm_2124B66E70B5.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 61,876,000,000 United States dollar | superseded | [clm_13A4177E72E9](/claim/clm_13A4177E72E9.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 20,997,000,000 United States dollar | superseded | [clm_C75019B7A8F6](/claim/clm_C75019B7A8F6.md) - 2023-04-28 to 2023-07-31 | money | shares_outstanding | 1,247,352,689 shares | superseded | [clm_59F0A1944F37](/claim/clm_59F0A1944F37.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 1,045,000,000 United States dollar | superseded | [clm_4FEA1639B883](/claim/clm_4FEA1639B883.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 1,665,000,000 United States dollar | superseded | [clm_28DC5CDFDC6E](/claim/clm_28DC5CDFDC6E.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 6,599,000,000 United States dollar | superseded | [clm_1E9F69BD5141](/claim/clm_1E9F69BD5141.md) - 2023-06-30 to 2023-09-30 | money | total_assets | 62,337,000,000 United States dollar | superseded | [clm_3CB17C366E6F](/claim/clm_3CB17C366E6F.md) - 2023-06-30 to 2023-09-30 | money | total_equity | 21,158,000,000 United States dollar | superseded | [clm_7D955D2EB31A](/claim/clm_7D955D2EB31A.md) - 2023-07-31 to 2023-10-31 | money | shares_outstanding | 1,246,014,353 shares | superseded | [clm_C916C69CA972](/claim/clm_C916C69CA972.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 2,180,000,000 United States dollar | superseded | [clm_51DCA48FA664](/claim/clm_51DCA48FA664.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 2,623,000,000 United States dollar | superseded | [clm_C0C3423DA043](/claim/clm_C0C3423DA043.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 7,051,000,000 United States dollar | superseded | [clm_56E2DDB08CBD](/claim/clm_56E2DDB08CBD.md) - 2023-09-30 to 2023-12-31 | money | total_assets | 62,373,000,000 United States dollar | superseded | [clm_FFEC37313BA6](/claim/clm_FFEC37313BA6.md) - 2023-09-30 to 2023-12-31 | money | total_equity | 22,314,000,000 United States dollar | superseded | [clm_ED56476EC42A](/claim/clm_ED56476EC42A.md) - 2023-10-31 to 2024-02-16 | money | shares_outstanding | 1,246,041,895 shares | superseded | [clm_71C62A492740](/claim/clm_71C62A492740.md) - 2023-12-31 to 2024-12-31 | money | net_income | 5,665,000,000 United States dollar | superseded | [clm_9ED5DC7A3225](/claim/clm_9ED5DC7A3225.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 7,605,000,000 United States dollar | superseded | [clm_4C71B25EAE57](/claim/clm_4C71B25EAE57.md) - 2023-12-31 to 2024-12-31 | money | revenue | 27,116,000,000 United States dollar | superseded | [clm_ABFE2CB3CF48](/claim/clm_ABFE2CB3CF48.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 62,125,000,000 United States dollar | superseded | [clm_E936AA9A1E59](/claim/clm_E936AA9A1E59.md) - 2023-12-31 to 2024-03-31 | money | total_equity | 22,833,000,000 United States dollar | superseded | [clm_49E88DCFA6FB](/claim/clm_49E88DCFA6FB.md) ## 2024 - 2024-02-16 to 2024-04-30 | money | shares_outstanding | 1,245,774,616 shares | superseded | [clm_692B7931D366](/claim/clm_692B7931D366.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | -4,170,000,000 United States dollar | superseded | [clm_A44E55A2C823](/claim/clm_A44E55A2C823.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | -4,322,000,000 United States dollar | superseded | [clm_08D7EEBC38FF](/claim/clm_08D7EEBC38FF.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 6,686,000,000 United States dollar | superseded | [clm_C8DA722C3664](/claim/clm_C8DA722C3664.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 56,292,000,000 United States dollar | superseded | [clm_B9F5256DAECB](/claim/clm_B9F5256DAECB.md) - 2024-03-31 to 2024-06-30 | money | total_equity | 17,539,000,000 United States dollar | superseded | [clm_64A76DECC383](/claim/clm_64A76DECC383.md) - 2024-04-30 to 2024-07-31 | money | shares_outstanding | 1,245,853,209 shares | superseded | [clm_FA8BB7DB6F61](/claim/clm_FA8BB7DB6F61.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 1,614,000,000 United States dollar | superseded | [clm_7098E59481B8](/claim/clm_7098E59481B8.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 2,644,000,000 United States dollar | superseded | [clm_AAD6E4F85DC7](/claim/clm_AAD6E4F85DC7.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 6,954,000,000 United States dollar | superseded | [clm_18BCC2F491A8](/claim/clm_18BCC2F491A8.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 53,579,000,000 United States dollar | superseded | [clm_481B3C5AC3EB](/claim/clm_481B3C5AC3EB.md) - 2024-06-30 to 2024-09-30 | money | total_equity | 18,281,000,000 United States dollar | superseded | [clm_7EE809D238E0](/claim/clm_7EE809D238E0.md) - 2024-07-31 to 2024-10-31 | money | shares_outstanding | 1,244,992,081 shares | superseded | [clm_19FC99911C58](/claim/clm_19FC99911C58.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 1,253,000,000 United States dollar | superseded | [clm_0F6781A0229E](/claim/clm_0F6781A0229E.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 888,000,000 United States dollar | superseded | [clm_7DD62F33711D](/claim/clm_7DD62F33711D.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 7,545,000,000 United States dollar | superseded | [clm_39562DEC6D14](/claim/clm_39562DEC6D14.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 54,525,000,000 United States dollar | superseded | [clm_3E93DA6B7ADB](/claim/clm_3E93DA6B7ADB.md) - 2024-09-30 to 2024-12-31 | money | total_equity | 18,475,000,000 United States dollar | superseded | [clm_F14A51AD91E7](/claim/clm_F14A51AD91E7.md) - 2024-10-31 to 2025-02-21 | money | shares_outstanding | 1,246,265,857 shares | superseded | [clm_9DC09EC0227B](/claim/clm_9DC09EC0227B.md) - 2024-12-31 to 2025-12-31 | money | net_income | 480,000,000 United States dollar | superseded | [clm_D66A9204BCB4](/claim/clm_D66A9204BCB4.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 1,662,000,000 United States dollar | superseded | [clm_9D8D94D516C5](/claim/clm_9D8D94D516C5.md) - 2024-12-31 to 2025-12-31 | money | revenue | 28,754,000,000 United States dollar | superseded | [clm_766F0DC2656D](/claim/clm_766F0DC2656D.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 58,995,000,000 United States dollar | superseded | [clm_39D2F7153DDD](/claim/clm_39D2F7153DDD.md) - 2024-12-31 to 2025-03-31 | money | total_equity | 19,330,000,000 United States dollar | superseded | [clm_4AF8C0C466F3](/claim/clm_4AF8C0C466F3.md) ## 2025 - 2025-02-21 to 2025-04-30 | money | shares_outstanding | 1,245,346,062 shares | superseded | [clm_2BEB2DBADF20](/claim/clm_2BEB2DBADF20.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 1,315,000,000 United States dollar | superseded | [clm_AB2BA2625080](/claim/clm_AB2BA2625080.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 2,237,000,000 United States dollar | superseded | [clm_C7852A733EB8](/claim/clm_C7852A733EB8.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 6,667,000,000 United States dollar | superseded | [clm_4E922360F385](/claim/clm_4E922360F385.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 56,434,000,000 United States dollar | superseded | [clm_3A96D6D8CC27](/claim/clm_3A96D6D8CC27.md) - 2025-03-31 to 2025-06-30 | money | total_equity | 19,162,000,000 United States dollar | superseded | [clm_096B626AF41F](/claim/clm_096B626AF41F.md) - 2025-04-30 to 2025-07-31 | money | shares_outstanding | 1,243,929,121 shares | superseded | [clm_00BBB280CB5F](/claim/clm_00BBB280CB5F.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 1,960,000,000 United States dollar | superseded | [clm_96F4B471EBB0](/claim/clm_96F4B471EBB0.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 2,474,000,000 United States dollar | superseded | [clm_126ADC7BE802](/claim/clm_126ADC7BE802.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 7,082,000,000 United States dollar | superseded | [clm_E0FB0CBAE021](/claim/clm_E0FB0CBAE021.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 55,721,000,000 United States dollar | superseded | [clm_CE3CB21B31C4](/claim/clm_CE3CB21B31C4.md) - 2025-06-30 to 2025-09-30 | money | total_equity | 19,674,000,000 United States dollar | superseded | [clm_C86E2D68884A](/claim/clm_C86E2D68884A.md) - 2025-07-31 to 2025-10-31 | money | shares_outstanding | 1,240,806,916 shares | superseded | [clm_9C3AF96BA25F](/claim/clm_9C3AF96BA25F.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 3,052,000,000 United States dollar | superseded | [clm_8C716505DCB2](/claim/clm_8C716505DCB2.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 3,327,000,000 United States dollar | superseded | [clm_E88E046C7258](/claim/clm_E88E046C7258.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 7,769,000,000 United States dollar | superseded | [clm_3A5203A42518](/claim/clm_3A5203A42518.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 58,533,000,000 United States dollar | superseded | [clm_5B9243C901AF](/claim/clm_5B9243C901AF.md) - 2025-09-30 to 2025-12-31 | money | total_equity | 21,540,000,000 United States dollar | superseded | [clm_B2A4004D2607](/claim/clm_B2A4004D2607.md) - 2025-10-31 to 2026-02-13 | money | shares_outstanding | 1,240,679,623 shares | superseded | [clm_5E452E3F3A54](/claim/clm_5E452E3F3A54.md) - 2025-12-31 | money | net_income | 8,510,000,000 United States dollar | valid | [clm_075AC6F097D8](/claim/clm_075AC6F097D8.md) - 2025-12-31 | money | operating_income | 10,022,000,000 United States dollar | valid | [clm_44AE227A69DA](/claim/clm_44AE227A69DA.md) - 2025-12-31 | money | revenue | 29,443,000,000 United States dollar | valid | [clm_5E2D1C5DC1DC](/claim/clm_5E2D1C5DC1DC.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 59,023,000,000 United States dollar | superseded | [clm_06C160F8C3A5](/claim/clm_06C160F8C3A5.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 22,703,000,000 United States dollar | superseded | [clm_994B784F55A6](/claim/clm_994B784F55A6.md) ## 2026 - 2026-02-13 to 2026-04-30 | money | shares_outstanding | 1,241,420,528 shares | superseded | [clm_E2DB5E0B53B4](/claim/clm_E2DB5E0B53B4.md) - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 2,021,000,000 United States dollar | superseded | [clm_24FF1FC3A935](/claim/clm_24FF1FC3A935.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 2,586,000,000 United States dollar | superseded | [clm_3305AD308056](/claim/clm_3305AD308056.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 6,960,000,000 United States dollar | superseded | [clm_5B00A751741D](/claim/clm_5B00A751741D.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 56,278,000,000 United States dollar | superseded | [clm_84AD5CE96A78](/claim/clm_84AD5CE96A78.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 23,515,000,000 United States dollar | superseded | [clm_E5496920DE7C](/claim/clm_E5496920DE7C.md) - 2026-04-30 to 2026-07-31 | money | shares_outstanding | 1,241,569,874 shares | superseded | [clm_453FCFB7AC1C](/claim/clm_453FCFB7AC1C.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | -10,496,000,000 United States dollar | superseded | [clm_9D61925E21DF](/claim/clm_9D61925E21DF.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | -10,394,000,000 United States dollar | superseded | [clm_D52EB913CD0D](/claim/clm_D52EB913CD0D.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 7,803,000,000 United States dollar | superseded | [clm_2C725370A4DF](/claim/clm_2C725370A4DF.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 49,362,000,000 United States dollar | superseded | [clm_64932ED26A58](/claim/clm_64932ED26A58.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 11,829,000,000 United States dollar | superseded | [clm_3745BC3CD67C](/claim/clm_3745BC3CD67C.md) - 2026-07-31 to 2026-10-23 | money | shares_outstanding | 1,239,955,155 shares | superseded | [clm_87D3256ADA54](/claim/clm_87D3256ADA54.md) - 2026-09-30 | money | quarterly_net_income | 2,429,000,000 United States dollar | valid | [clm_4B6581046BE2](/claim/clm_4B6581046BE2.md) - 2026-09-30 | money | quarterly_operating_income | 3,462,000,000 United States dollar | valid | [clm_8490C244F9F5](/claim/clm_8490C244F9F5.md) - 2026-09-30 | money | quarterly_revenue | 8,300,000,000 United States dollar | valid | [clm_64E20B8C7E0A](/claim/clm_64E20B8C7E0A.md) - 2026-09-30 | money | total_assets | 51,408,000,000 United States dollar | valid | [clm_53C30342724D](/claim/clm_53C30342724D.md) - 2026-09-30 | money | total_equity | 13,040,000,000 United States dollar | valid | [clm_F5C77DE07AFE](/claim/clm_F5C77DE07AFE.md) - 2026-10-23 | money | shares_outstanding | 1,240,338,614 shares | valid | [clm_3ADDE79BC725](/claim/clm_3ADDE79BC725.md) ## undated - undated | other | cik | 0000882095 | valid | [clm_3A93D2D56CBA](/claim/clm_3A93D2D56CBA.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_58190642DD33](/claim/clm_58190642DD33.md) - undated | other | headquarters | Foster City | valid | [clm_3AA77CFFBA18](/claim/clm_3AA77CFFBA18.md) - undated | other | listed_on | Nasdaq | valid | [clm_79DB7756109C](/claim/clm_79DB7756109C.md) - undated | other | sic_industry | Biological Products, (No Diagnostic Substances) (2836) | valid | [clm_44B0DF6C61E1](/claim/clm_44B0DF6C61E1.md) - undated | other | state_of_incorporation | DE | valid | [clm_433BC2407C2F](/claim/clm_433BC2407C2F.md) - undated | other | ticker | GILD | valid | [clm_ACCCAF058EE1](/claim/clm_ACCCAF058EE1.md) - undated | other | website | https://www.gilead.com/ | unverified | [clm_6FC170F46335](/claim/clm_6FC170F46335.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.